Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Strata Skin Sciences, Inc. (SSKN) had Revenue of $7.66M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$7.66M
Net Income	$-2.49M
Cost of Goods Sold	$3.36M
Gross Profit	$4.31M
Operating Expenses	$9.89M
Operating Income	$-2.22M
Non-Operating Income/Expense	$-0.27M
Pre-Tax Income	$-2.49M
Normalized Pre-Tax Income	$-2.49M
Income after Taxes	$-2.49M
Income from Continuous Operations	$-2.49M
Consolidated Net Income/Loss	$-2.49M
Normalized Income after Taxes	$-2.49M
EBIT	$-2.22M
EBITDA	$-0.88M
Weighted-Average Shares Outstanding (Basic)	4.17M
Weighted-Average Shares Outstanding (Diluted)	4.17M
Earnings per Share (EPS) (Basic)	$-0.60
Earnings per Share (EPS) (Diluted)	$-0.60
Balance Sheet Financials
Current Assets	$13.77M
Property, Plant, and Equipment	$8.60M
Long-Term Assets	$16.95M
Total Assets	$30.72M
Current Liabilities	$14.00M
Long-Term Debt	$15.27M
Long-Term Liabilities	$16.41M
Total Liabilities	$30.41M
Common Equity	$0.31M
Tangible Shareholders Equity	$-6.71M
Shareholders Equity	$0.31M
Common Shares Outstanding	4.17M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.49M
Cash Flow from Investing Activities	$-0.14M
Cash Flow from Financial Activities	--
Beginning Cash	$8.60M
End Cash	$5.97M
Increase/Decrease in Cash	$-2.63M
Stock-Based Compensation	$0.26M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.98
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.98
Debt to Equity Ratio	49.58
Gross Margin	56.19%
Operating Margin	-29.02%
EBIT Margin	-29.02%
EBITDA Margin	--
Pre-Tax Profit Margin	-32.48%
Profit Margin	-32.48%
Free Cash Flow	$-2.63M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.25
Inventory Turnover	1.04
Receiveable Turnover	1.91
Days Sales in Receivables	47.24
Return on Equity	-808.12%
Return on Tangible Equity	37.08%
Return on Assets	-8.10%
Return on Investments	-15.98%
Book Value Per Share	$0.07
Free Cash Flow per Share	$-0.63
Operating Cash Flow per Share	$-0.60

Data from Zacks Investment Research, Inc.